Brian Normand

Brian Normand

Brian Normand is CoFounder of Psymposia, an ex-cannabis grower, greenthumb with a B.S. in Plant, Soil, and Insect Sciences, and Airbnb superhost, focused on changing minds about plants and drugs.

Join us at the CryptoPsychedelic summit in Tulum, Mexico

The summit will bring together voices in psychedelic research, advocacy, drug reform, and blockchain technology.

Is ibogaine the cure for opioid addiction? It’s not that simple.

The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.

Ibogaine treatment comes with risks. We had a discussion about safety with medical providers.

The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.

How safe is ibogaine? We asked Clare Wilkins who has facilitated over 700 treatments

The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.

2017 Year in Review

2017 was a special year for us. Here’s our favorite highlights.

How Not to Do Ibogaine 101 with Juliana Mulligan

The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former underground provider, Dimitri Mugianis, on the regulation of ibogaine

The Ibogaine Conversation Part 7 | Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door.

Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine

The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.

Talking ibogaine research for opioid addiction with Thomas Kingsley Brown

The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.

We are Bwitists and healers in Gabon. Here’s what we think of the global interest in iboga.

The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.